Veraxa Biotech AG - Post de-SPAC (VRXA): who owns it and who trades it
As of Oct 30, 2026, VRXA insiders reported 5 purchases worth $125K in the last 12 months. The largest buyer was Oliver Rolf Baumann (Director), with $75K.
Latest filing Oct 30, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
In the last 12 months, VRXA insiders reported $125K of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | Marc Gruninger | Director | Purchase | 9,133 | $1.00 | $9.1K | Form 4 |
| Oct 27, 2026 | Marc Gruninger | Director | Purchase | 867 | $0.98 | $850 | Form 4 |
| Oct 20, 2026 | Christoph Samuel Ziegler | Director | Purchase | 30,000 | $1.09 | $32.7K | Form 4 |
| Aug 27, 2026 | Oliver Rolf Baumann | Director | Purchase | 50,000 | $1.50 | $75K | Form 4 |
| Aug 27, 2026 | Christoph Rudiger Antz | CEO | Purchase | 5,000 | $1.53 | $7.7K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Oliver Rolf Baumann | Director | $75K | – | Aug 27, 2026 |
| Christoph Samuel Ziegler | Director | $32.7K | – | Oct 20, 2026 |
| Marc Gruninger | Director | $10K | – | Oct 28, 2026 |
| Christoph Rudiger Antz | Chief Executive Officer, Director | $7.7K | – | Aug 27, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
VRXA short interest
91,222 VRXA shares are sold short. Over the last 10 reports the number of shares short went up 796%.
As of Oct 30, 2026, 91,222 VRXA shares were sold short, down 15.0% from the report before. At the average daily volume of 164,496 shares, buying them all back would take about 1.0 trading days (days to cover).
Shares short
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 91,222 | – | -15% | 164,496 | 1.0 |
| Oct 15, 2026 | 107,383 | – | -54% | 421,031 | 1.0 |
| Sep 30, 2026 | 235,019 | – | +12% | 51,432 | 4.6 |
| Sep 15, 2026 | 209,727 | – | +3% | 584,112 | 1.0 |
| Aug 31, 2026 | 202,960 | – | -46% | 204,024 | 1.0 |
| Aug 14, 2026 | 378,219 | – | -5% | 104,063 | 3.6 |
| Jul 31, 2026 | 399,577 | – | +66% | 322,030 | 1.2 |
| Jul 15, 2026 | 240,554 | – | +82% | 1.73M | 1.0 |
| Jun 30, 2026 | 131,851 | – | +1196% | 548,316 | 1.0 |
| Jun 15, 2026 | 10,176 | – | – | 9,811 | 1.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Questions about Veraxa Biotech AG - Post de-SPAC (VRXA) stock
Are VRXA insiders buying or selling?
In the last 12 months, VRXA insiders reported 5 open-market purchases worth $125K and no sales. The latest trade was on Oct 28, 2026. See every trade.
What is the short interest in VRXA?
As of Oct 30, 2026, 91,222 VRXA shares were sold short, down 15.0% from the report before. At the average daily volume of 164,496 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.